Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara. [PDF]
Pharmaceuticals (Basel), 2022 Jiménez de Oya N +7 more
europepmc +1 more source
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara–Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial [PDF]
, 2018 Rory D. de Vries +14 more
openalex +1 more source
Diversity of cell death signaling pathways in macrophages upon infection with modified vaccinia virus Ankara (MVA). [PDF]
Cell Death Dis, 2021 Klaas L +4 more
europepmc +1 more source
Long-Term Control of Simian Immunodeficiency Virusmac251 Viremia to Undetectable Levels in Half of Infected Female Rhesus Macaques Nasally Vaccinated with Simian Immunodeficiency Virus DNA/Recombinant Modified Vaccinia Virus Ankara [PDF]
, 2011 Mariana Manrique +8 more
openalex +1 more source
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans [PDF]
, 2003 Samuel McConkey +27 more
openalex +1 more source
Functional characterization of modified vaccinia virus Ankara-encoded anti-apoptotic proteins
, 2009 Candidate vaccines based on the highly attenuated orthopoxvirus strain MVA are tested against various infectious and cancer diseases and, more profound, vaccines based on wildtype and recombinant viruses have been found safe and immunogenic in clinical trials.
openaire +3 more sources